Optical coherence tomography-based decision making in exudative age-related macular degeneration: Comparison of time- vs spectral-domain devices

Eye

Volumn 24, Issue 5, 2010, Pages 775-783

  Cukras, C ^a   Wang, Y D ^a   Meyerle, C B ^a   Forooghian, F ^a   Chew, E Y ^a   Wong, W T ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Age related macular degeneration; Anti angiogenic treatment; Clinical trials; Neovascularization; Optical coherence tomography

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; HUMAN; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL FLUID;

EID: 77952517230     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.211     Document Type: Article

References (16)

1. Hee MR, Baumal CR, Puliafito CA, Duker JS, Reichel E, Wilkins JR et al. Optical coherence tomography of agerelated macular degeneration and choroidal neovascularization. Ophthalmology 1996;103: 1260-1270. (Pubitemid 26282510)
2. Jaffe GJ, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol 2004;137: 156-169. (Pubitemid 38045202)
3. Moshfeghi AA, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD et al. Systemic bevacizumab (avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study. Ophthalmology 2006;113: 2002 e2001-2012.
4. Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143: 566-583.
5. Kaiser PK, Blodi BA, Shapiro H, Acharya NR. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular agerelated macular degeneration. Ophthalmology 2007;114: 1868-1875.
6. Polito A, Del Borrello M, Isola M, Zemella N, Bandello F. Repeatability and reproducibility of fast macular thickness mapping with stratus optical coherence tomography. Arch Ophthalmol 2005;123: 1330-1337.
7. Danis RP, Fisher MR, Lambert E, Goulding A, Wu D, Lee LY. Results and repeatability of retinal thickness measurements from certification submissions. Arch Ophthalmol 2008;126: 45-50.
8. Massin P, Vicaut E, Haouchine B, Erginay A, Paques M, Gaudric A. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 2001;119: 1135-1142.
9. Bernardes R, Santos T, Cunha-Vaz J. Increased-resolution OCT thickness mapping of the human macula: a statistically based registration. Invest Ophthalmol Vis Sci 2008;49: 2046-2052.
10. Zhang N, Hoffmeyer GC, Young ES, Burns RE, Winter KP, Stinnett SS et al. Optical coherence tomography reader agreement in neovascular age-related macular degeneration. Am J Ophthalmol 2007;144: 37-44.
11. Keane PA, Liakopoulos S, Jivrajka RV, Chang KT, Alasil T, Walsh AC et al. Evaluation of optical coherence tomography central retinal thickness parameters for use as anatomic outcomes in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50(7):3378-3385.
12. Brown DM, Regillo CD. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol 2007;144: 627-637.
13. Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W et al. Intravitreal bevacizumab (avastin) therapy vs photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study. Br J Ophthalmol 2008;92: 356-360.
14. Holz FG, Jorzik J, Schutt F, Flach U, Unnebrink K. Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study). Ophthalmology 2003;110: 400-405. (Pubitemid 36184347)
15. Taban M, Sharma S, Williams DR, Waheed N, Kaiser PK. Comparing retinal thickness measurements using automated fast macular thickness map vs six-radial line scans with manual measurements. Ophthalmology 2009;116: 964-970.
16. Sayanagi K, Sharma S, Yamamoto T, Kaiser PK. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. Ophthalmology 2009;116(5):947-955.